- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00004859
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
A Randomized Phase III Trial of Carboplatin, Paclitaxel and Thoracic Radiotherapy, With or Without Thalidomide, in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC)
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
OBJECTIVES:
I. Compare the survival and time to progression of patients with stage IIIA or IIIB non-small cell lung cancer when treated with carboplatin, paclitaxel, and chemoradiotherapy with or without thalidomide.
II. Evaluate the toxicity of the thalidomide-containing regimen and compare response rates of the two groups.
III. Determine whether the inactivation of p16, Death-associated protein kinase (DAP-kinase), O6-methylguanine-DNA methyltransferase (MGMT) gene, or tissue-inhibitor of metalloproteinase 3 (TIMP-3) genes can be used to predict survival in these patients treated with this regimen.
IV. Determine whether the detection of a methylation biomarker in serum can be used to predict survival in these patients treated with this regimen.
OUTLINE: This is a randomized study. Patients are stratified according to disease histology (squamous vs nonsquamous), performance status (0 vs 1), disease stage (IIIA vs IIIB), and time of randomization (before addition of chemoradiotherapy vs after). Patients are randomized to one of two treatment arms.
ARM A: Patients receive paclitaxel intravenously (IV) over 3 hours immediately followed by carboplatin IV over 15-30 minutes on days 1 and 22. Treatment continues every 22 days in the absence of unacceptable toxicity or disease progression.
ARM B: Patients receive paclitaxel and carboplatin as in arm A. Patients also receive oral thalidomide and oral low-dose aspirin daily beginning on day 1 for up to 24 months in the absence of disease progression.
Beginning between days 43-50, patients in both arms with stable or responding disease receive chemoradiotherapy comprising paclitaxel IV over 1 hour and carboplatin IV over 15-30 minutes once weekly for 6 weeks and radiotherapy (RT) 5 days a week for 6 weeks. Arm B patients continue oral thalidomide.
Patients are followed every 2 months for 2 years and then every 6 months for 3 years.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
Arkansas
-
Ft. Smith, Arkansas, Stati Uniti, 72903
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
-
-
California
-
Modesto, California, Stati Uniti, 95355
- Memorial Medical Center Cancer Services
-
Salinas, California, Stati Uniti, 93901
- Salinas Valley Memorial Hospital
-
Stanford, California, Stati Uniti, 94305
- Stanford Comprehensive Cancer Center at Stanford University Medical Center
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80012
- Aurora Presbyterian Hospital
-
Boulder, Colorado, Stati Uniti, 80301-9019
- Boulder Community Hospital
-
Colorado Springs, Colorado, Stati Uniti, 80933
- Penrose Cancer Center at Penrose Hospital
-
Colorado Springs, Colorado, Stati Uniti, 80909
- Memorial Hospital
-
Denver, Colorado, Stati Uniti, 80210
- Porter Adventist Hospital
-
Denver, Colorado, Stati Uniti, 80220
- Rose Medical Center
-
Denver, Colorado, Stati Uniti, 80218
- Presbyterian - St. Luke's Medical Center
-
Denver, Colorado, Stati Uniti, 80218
- St. Joseph Hospital
-
Denver, Colorado, Stati Uniti, 80224-2522
- CCOP - Colorado Cancer Research Program, Incorporated
-
Englewood, Colorado, Stati Uniti, 80110
- Swedish Medical Center
-
Grand Junction, Colorado, Stati Uniti, 81502
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
-
Lone Tree, Colorado, Stati Uniti, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, Stati Uniti, 80502
- Hope Cancer Care Center at Longmont United Hospital
-
Pueblo, Colorado, Stati Uniti, 81004
- St. Mary-Corwin Regional Medical Center
-
Thornton, Colorado, Stati Uniti, 80229
- North Suburban Medical Center
-
-
Connecticut
-
Danbury, Connecticut, Stati Uniti, 06810
- Praxair Cancer Center at Danbury Hospital
-
Norwich, Connecticut, Stati Uniti, 06360
- William W. Backus Hospital
-
-
Florida
-
Daytona Beach, Florida, Stati Uniti, 32115
- Halifax Medical Center - Daytona Beach
-
Jacksonville, Florida, Stati Uniti, 32207
- Baptist Cancer Institute - Jacksonville
-
-
Georgia
-
Augusta, Georgia, Stati Uniti, 30912
- MBCCOP - Medical College of Georgia Cancer Center
-
Augusta, Georgia, Stati Uniti, 30904
- Veterans Affairs Medical Center - Augusta
-
Decatur, Georgia, Stati Uniti, 30033
- Veterans Affairs Medical Center - Atlanta (Decatur)
-
Macon, Georgia, Stati Uniti, 31208
- Medical Center of Central Georgia
-
Savannah, Georgia, Stati Uniti, 31403-3089
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
-
Valdosta, Georgia, Stati Uniti, 31603
- Pearlman Comprehensive Cancer Center at South Georgia Medical Center
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60611-3013
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
-
Chicago, Illinois, Stati Uniti, 60625
- Swedish Covenant Hospital
-
Chicago, Illinois, Stati Uniti, 60616
- Mercy Hospital and Medical Center
-
Hinsdale, Illinois, Stati Uniti, 60521
- Hinsdale Hematology Oncology Associates
-
Joliet, Illinois, Stati Uniti, 60432
- Midwest Center for Hematology/Oncology
-
Moline, Illinois, Stati Uniti, 61265
- Trinity Medical Center - East
-
Rockford, Illinois, Stati Uniti, 61104-2315
- Swedish-American Regional Cancer Center
-
Skokie, Illinois, Stati Uniti, 60076
- Hematology/Oncology of the North Shore at Gross Point Medical Center
-
-
Indiana
-
Elkhart, Indiana, Stati Uniti, 46515
- Elkhart General Hospital
-
Kokomo, Indiana, Stati Uniti, 46904
- Howard Community Hospital at Howard Regional Health System
-
La Porte, Indiana, Stati Uniti, 46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
Richmond, Indiana, Stati Uniti, 47374
- Reid Hospital & Health Care Services, Incorporated
-
South Bend, Indiana, Stati Uniti, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, Stati Uniti, 46601
- CCOP - Northern Indiana CR Consortium
-
South Bend, Indiana, Stati Uniti, 46617
- Saint Joseph Regional Medical Center
-
-
Iowa
-
Bettendorf, Iowa, Stati Uniti, 52722
- Hematology Oncology Associates of the Quad Cities
-
Cedar Rapids, Iowa, Stati Uniti, 52402
- St. Luke's Hospital
-
Cedar Rapids, Iowa, Stati Uniti, 52403
- Cedar Rapids Oncology Associates
-
Cedar Rapids, Iowa, Stati Uniti, 52403
- Mercy Regional Cancer Center at Mercy Medical Center
-
Davenport, Iowa, Stati Uniti, 52803
- Genesis Regional Cancer Center at Genesis Medical Center
-
Des Moines, Iowa, Stati Uniti, 50309
- CCOP - Iowa Oncology Research Association
-
Des Moines, Iowa, Stati Uniti, 50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines, Iowa, Stati Uniti, 50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines, Iowa, Stati Uniti, 50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines, Iowa, Stati Uniti, 50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Stati Uniti, 50307
- Mercy Capitol Hospital
-
Des Moines, Iowa, Stati Uniti, 50316-2301
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Sioux City, Iowa, Stati Uniti, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, Stati Uniti, 51104
- St. Luke's Regional Medical Center
-
Sioux City, Iowa, Stati Uniti, 51104
- Mercy Medical Center - Sioux City
-
West Des Moines, Iowa, Stati Uniti, 50266
- Medical Oncology and Hematology Associates - West Des Moines
-
-
Kentucky
-
Madisonville, Kentucky, Stati Uniti, 42431
- Merle M. Mahr Cancer Center at Regional Medical Center of Hopkins County
-
-
Maryland
-
Annapolis, Maryland, Stati Uniti, 21401
- DeCesaris Cancer Institute at Anne Arundel Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02111
- Tufts-NEMC Cancer Center
-
Newton, Massachusetts, Stati Uniti, 02462
- Newton-Wellesley Hospital
-
Springfield, Massachusetts, Stati Uniti, 01199
- Baystate Regional Cancer Program at D'Amour Center for Cancer Care
-
Taunton, Massachusetts, Stati Uniti, 02780
- Morton Hospital & Medical Center
-
-
Michigan
-
Adrian, Michigan, Stati Uniti, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, Stati Uniti, 48106
- CCOP - Michigan Cancer Research Consortium
-
Ann Arbor, Michigan, Stati Uniti, 48106-0995
- St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
-
Dearborn, Michigan, Stati Uniti, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba, Michigan, Stati Uniti, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, Stati Uniti, 48503
- Hurley Medical Center
-
Flint, Michigan, Stati Uniti, 48503
- Genesys Hurley Cancer Institute
-
Grosse Pointe Woods, Michigan, Stati Uniti, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, Stati Uniti, 49801
- Green Bay Oncology, Limited - Iron Mountain
-
Jackson, Michigan, Stati Uniti, 49201
- Foote Hospital
-
Kalamazoo, Michigan, Stati Uniti, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Stati Uniti, 49007-3731
- West Michigan Cancer Center
-
Kalamazooaa, Michigan, Stati Uniti, 49001
- Borgess Medical Center
-
Lambertville, Michigan, Stati Uniti, 48144
- Haematology-Oncology Associates of Ohio and Michigan, PC
-
Lansing, Michigan, Stati Uniti, 48909
- Sparrow Regional Cancer Center
-
Monroe, Michigan, Stati Uniti, 48162
- Mercy Memorial Hospital System
-
Saginaw, Michigan, Stati Uniti, 48601
- Seton Cancer Institute - Saginaw
-
St. Joseph, Michigan, Stati Uniti, 49085
- Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph
-
Warren, Michigan, Stati Uniti, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Stati Uniti, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Stati Uniti, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Duluth, Minnesota, Stati Uniti, 55805
- CCOP - Duluth
-
Duluth, Minnesota, Stati Uniti, 55805
- St. Mary's - Duluth Clinic Cancer Center
-
Duluth, Minnesota, Stati Uniti, 55805
- Miller-Dwan Medical Center
-
Edina, Minnesota, Stati Uniti, 55435
- Fairview Southdale Hospital
-
Fergus Falls, Minnesota, Stati Uniti, 56537
-
Fridley, Minnesota, Stati Uniti, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson, Minnesota, Stati Uniti, 55350
- Hutchinson Area Health Care
-
Lichfield, Minnesota, Stati Uniti, 55355
- Meeker County Memorial Hospital
-
Maplewood, Minnesota, Stati Uniti, 55109
- HealthEast Cancer Care at St. John's Hospital
-
Minneapolis, Minnesota, Stati Uniti, 55415
- Hennepin County Medical Center - Minneapolis
-
Minneapolis, Minnesota, Stati Uniti, 55407
- Virginia Piper Cancer Institute at Abbott-Northwestern Hospital
-
Robbinsdale, Minnesota, Stati Uniti, 55422-2900
- Hubert H. Humphrey Cancer Center at North Memorial Medical Center
-
Saint Louis Park, Minnesota, Stati Uniti, 55416
- CCOP - Metro-Minnesota
-
Shakopee, Minnesota, Stati Uniti, 55379
- Saint Francis Cancer Center
-
St Paul, Minnesota, Stati Uniti, 55102
- St. Joseph's Hospital
-
St. Cloud, Minnesota, Stati Uniti, 56303
- CentraCare Clinic - River Campus
-
St. Louis Park, Minnesota, Stati Uniti, 55416
- Park Nicollet Health Services
-
St. Paul, Minnesota, Stati Uniti, 55102
- United Hospital
-
St. Paul, Minnesota, Stati Uniti, 55101
- Regions Hospital Cancer Care Center
-
Waconia, Minnesota, Stati Uniti, 55387
- Ridgeview Medical Center
-
Woodbury, Minnesota, Stati Uniti, 55125
- Woodwinds Health Campus
-
-
Missouri
-
Kansas City, Missouri, Stati Uniti, 64131
- CCOP - Kansas City
-
Springfield, Missouri, Stati Uniti, 65804
- St. John's Regional Health Center
-
Springfield, Missouri, Stati Uniti, 65807
- Hulston Cancer Center at Cox Medical Center South
-
St. Louis, Missouri, Stati Uniti, 63131
- Missouri Baptist Cancer Center
-
-
Montana
-
Billings, Montana, Stati Uniti, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, Stati Uniti, 59101
- Northern Rockies Radiation Oncology Center
-
Billings, Montana, Stati Uniti, 59107-7000
- Deaconess Billings Clinic - Downtown
-
Great Falls, Montana, Stati Uniti, 59405
- Great Falls Clinic
-
Great Falls, Montana, Stati Uniti, 59405
-
Great Falls, Montana, Stati Uniti, 59405
- Big Sky Oncology
-
Great Falls, Montana, Stati Uniti, 59405
- Sletten Regional Cancer Institute at Benefis Healthcare
-
-
Nebraska
-
Lincoln, Nebraska, Stati Uniti, 68510
- Cancer Resource Center - Lincoln
-
Omaha, Nebraska, Stati Uniti, 68106
- CCOP - Missouri Valley Cancer Consortium
-
Omaha, Nebraska, Stati Uniti, 68122
- Immanuel Medical Center
-
Omaha, Nebraska, Stati Uniti, 68124
- Alegant Health Cancer Center at Bergan Mercy Medical Center
-
Omaha, Nebraska, Stati Uniti, 68131-2197
- Creighton University Medical Center
-
-
Nevada
-
Las Vegas, Nevada, Stati Uniti, 89106
- CCOP - Nevada Cancer Research Foundation
-
-
New Jersey
-
East Orange, New Jersey, Stati Uniti, 07018-1095
- Veterans Affairs Medical Center - East Orange
-
Flemington, New Jersey, Stati Uniti, 08822
- Hunterdon Regional Cancer Center at Hunterdon Medical Center
-
Hamilton, New Jersey, Stati Uniti, 08690
- Cancer Institute of New Jersey At Hamilton
-
Marlton, New Jersey, Stati Uniti, 08053
- Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
-
Montclair, New Jersey, Stati Uniti, 07042
- Mountainside Hospital Cancer Center
-
Morristown, New Jersey, Stati Uniti, 07962
- Carol G. Simon Cancer Center at Morristown Memorial Hospital
-
New Brunswick, New Jersey, Stati Uniti, 08903
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
-
Phillipsburg, New Jersey, Stati Uniti, 08865
- Warren Hospital
-
Red Bank, New Jersey, Stati Uniti, 07701
- Booker Cancer Center at Riverview Medical Center
-
Somers Point, New Jersey, Stati Uniti, 08244
- Shore Memorial Hospital - Somers Point
-
Summit, New Jersey, Stati Uniti, 07902
- Overlook Hospital
-
Voorhees, New Jersey, Stati Uniti, 08043
- Fox Chase Virtua Health Cancer Program at Virtua West Jersey
-
-
New York
-
Bronx, New York, Stati Uniti, 10461
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
-
Bronx, New York, Stati Uniti, 10466
- Our Lady of Mercy Medical Center Comprehensive Cancer Center
-
Buffalo, New York, Stati Uniti, 14215
- Veterans Affairs Medical Center - Buffalo
-
Rochester, New York, Stati Uniti, 14621
- Lipson Cancer and Blood Center at Rochester General Hospital
-
Syracuse, New York, Stati Uniti, 13057
- CCOP - Hematology-Oncology Associates of Central New York
-
-
North Carolina
-
Goldsboro, North Carolina, Stati Uniti, 27534
- Wayne Memorial Hospital, Incorporated
-
Wilson, North Carolina, Stati Uniti, 27893-3428
- Wilson Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, Stati Uniti, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, Stati Uniti, 58501
- Cancer Care Center at Medcenter One Hospital
-
Bismarck, North Dakota, Stati Uniti, 58501
- Mid Dakota Clinic, P. C.
-
Bismarck, North Dakota, Stati Uniti, 58502
- St. Alexius Medical Center
-
-
Ohio
-
Akron, Ohio, Stati Uniti, 44309-2090
- Akron City Hospital
-
Canton, Ohio, Stati Uniti, 44710-1799
- Aultman Hospital Cancer Center at Aultman Health Foundation
-
Chillicothe, Ohio, Stati Uniti, 45601
- Adena Regional Medical Center
-
Cleveland, Ohio, Stati Uniti, 44109
- MetroHealth's Cancer Care Center at MetroHealth Medical Center
-
Columbus, Ohio, Stati Uniti, 43214-3998
- Riverside Methodist Hospital Cancer Care
-
Columbus, Ohio, Stati Uniti, 43222
- Mount Carmel Health - West Hospital
-
Columbus, Ohio, Stati Uniti, 43215
- CCOP - Columbus
-
Columbus, Ohio, Stati Uniti, 43228
- Doctors Hospital at Ohio Health
-
Columbus, Ohio, Stati Uniti, 43215
- Grant Riverside Cancer Services
-
Dayton, Ohio, Stati Uniti, 45428
- Veterans Affairs Medical Center - Dayton
-
Dayton, Ohio, Stati Uniti, 45409
- David L. Rike Cancer Center at Miami Valley Hospital
-
Dayton, Ohio, Stati Uniti, 45415
- Samaritan North Cancer Care Center
-
Delaware, Ohio, Stati Uniti, 43015
- Grady Memorial Hospital
-
Findlay, Ohio, Stati Uniti, 45840
- Blanchard Valley Medical Associates
-
Fremont, Ohio, Stati Uniti, 43420
- Fremont Memorial Hospital
-
Kettering, Ohio, Stati Uniti, 45429
- Charles F. Kettering Memorial Hospital
-
Lancaster, Ohio, Stati Uniti, 43130
- Fairfield Medical Center
-
Lima, Ohio, Stati Uniti, 45804
- Lima Memorial Hospital
-
Lima, Ohio, Stati Uniti, 45801
- St. Rita's Medical Center
-
Mansfield, Ohio, Stati Uniti, 44903
- MedCentral - Mansfield Hospital
-
Marietta, Ohio, Stati Uniti, 45750
- Strecker Cancer Center at Marietta Memorial Hospital
-
Maumee, Ohio, Stati Uniti, 43537
- St. Luke's Hospital
-
Maumee, Ohio, Stati Uniti, 43623
- Northwest Ohio Oncology Center
-
Newark, Ohio, Stati Uniti, 43055
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
-
Oregon, Ohio, Stati Uniti, 43616
- St. Charles Mercy Hospital
-
Sandusky, Ohio, Stati Uniti, 44870
- Firelands Regional Medical Center
-
Springfield, Ohio, Stati Uniti, 45505
- Community Hospital of Springfield and Clark County
-
Springfield, Ohio, Stati Uniti, 45504
- Mercy Medical Center
-
Sylvania, Ohio, Stati Uniti, 43560
- Flower Hospital Cancer Center
-
Tiffin, Ohio, Stati Uniti, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Stati Uniti, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, Stati Uniti, 43606
- Toledo Hospital
-
Toledo, Ohio, Stati Uniti, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, Stati Uniti, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo, Ohio, Stati Uniti, 43623
- CCOP - Toledo Community Hospital
-
Troy, Ohio, Stati Uniti, 45373-1300
- UVMC Cancer Care Center at Upper Valley Medical Center
-
Wauseon, Ohio, Stati Uniti, 43567
- Fulton County Health Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Stati Uniti, 18105
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
-
Bryn Mawr, Pennsylvania, Stati Uniti, 19010
- Bryn Mawr Hospital
-
Danville, Pennsylvania, Stati Uniti, 17822-0001
- Geisinger Medical Center
-
Dubois, Pennsylvania, Stati Uniti, 15801
- Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center
-
Easton, Pennsylvania, Stati Uniti, 18042
- Easton Regional Cancer Center at Easton Hospital
-
Harrisburg, Pennsylvania, Stati Uniti, 17105
- PinnacleHealth Regional Cancer Center at Polyclinic Hospital
-
Hershey, Pennsylvania, Stati Uniti, 17033-0850
- Penn State Cancer Institute at Milton S. Hershey Medical Center
-
Lancaster, Pennsylvania, Stati Uniti, 17604
- Lancaster General Hospital
-
Lewistown, Pennsylvania, Stati Uniti, 17044
- Lewistown Hospital
-
Paoli, Pennsylvania, Stati Uniti, 19301-1792
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Stati Uniti, 19107
- Joan Karnell Cancer Center at Pennsylvania Hospital
-
Phoenixville, Pennsylvania, Stati Uniti, 19460
- Cancer Center at Phoenixville Hospital
-
Pittsburgh, Pennsylvania, Stati Uniti, 15212
- Allegheny Cancer Center at Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Stati Uniti, 15232
- Hillman Cancer Center at University of Pittsburgh Cancer Institute
-
Pottstown, Pennsylvania, Stati Uniti, 19464
- Pottstown Memorial Regional Cancer Center
-
Reading, Pennsylvania, Stati Uniti, 19612-6052
- Reading Hospital and Medical Center
-
Scranton, Pennsylvania, Stati Uniti, 18501
- Mercy Hospital Cancer Center - Scranton
-
Scranton, Pennsylvania, Stati Uniti, 18510
- Hematology and Oncology Associates
-
Sellersville, Pennsylvania, Stati Uniti, 18960
- Grand View Hospital
-
State College, Pennsylvania, Stati Uniti, 16803
- Mount Nittany Medical Center
-
West Grove, Pennsylvania, Stati Uniti, 19390-9499
- Jennersville Regional Hospital
-
Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
Wynnewood, Pennsylvania, Stati Uniti, 19096
- CCOP - MainLine Health
-
Wynnewood, Pennsylvania, Stati Uniti, 19096
- Lankenau Cancer Center at Lankenau Hospital
-
-
South Carolina
-
Aiken, South Carolina, Stati Uniti, 29801
- Cancer Care Institute of Carolina at Aiken Regional Medical Centers
-
Greenville, South Carolina, Stati Uniti, 29615
- CCOP - Greenville
-
-
South Dakota
-
Sioux Falls, South Dakota, Stati Uniti, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Stati Uniti, 57117-5039
- Sioux Valley Hospital and University of South Dakota Medical Center
-
Sioux Falls, South Dakota, Stati Uniti, 57105
- Medical X-Ray Center, PC
-
-
Tennessee
-
Kingsport, Tennessee, Stati Uniti, 37662
- Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
-
Nashville, Tennessee, Stati Uniti, 37208-3599
- MBCCOP - Meharry Medical College - Nashville
-
-
Texas
-
Temple, Texas, Stati Uniti, 76508
- CCOP - Scott and White Hospital
-
-
Virginia
-
Charlottesville, Virginia, Stati Uniti, 22908
- University of Virginia Cancer Center at UV Health System
-
Danville, Virginia, Stati Uniti, 24541
- Danville Regional Medical Center
-
Norton, Virginia, Stati Uniti, 24273
- Southwest Virginia Regional Cancer Center
-
Richmond, Virginia, Stati Uniti, 23298-0037
- Virginia Commonwealth University Massey Cancer Center
-
-
West Virginia
-
Charleston, West Virginia, Stati Uniti, 25304
- West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division
-
Huntington, West Virginia, Stati Uniti, 25701
- Marshall University Medical Center
-
-
Wisconsin
-
Green Bay, Wisconsin, Stati Uniti, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, Stati Uniti, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, Stati Uniti, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
Green Bay, Wisconsin, Stati Uniti, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital
-
La Crosse, Wisconsin, Stati Uniti, 54601
- Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Stati Uniti, 53792-6164
- University of Wisconsin Comprehensive Cancer Center
-
Madison, Wisconsin, Stati Uniti, 53717
- Dean Medical Center - Madison
-
Marinette, Wisconsin, Stati Uniti, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Marshfield, Wisconsin, Stati Uniti, 54449
- Marshfield Clinic - Marshfield Center
-
Oconto Falls, Wisconsin, Stati Uniti, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Racine, Wisconsin, Stati Uniti, 53405
- All Saints Cancer Center at All Saints Healthcare
-
Sturgeon Bay, Wisconsin, Stati Uniti, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
-
-
-
-
Pretoria, Sud Africa, 0001
- Pretoria Academic Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Histologically confirmed newly diagnosed non-small cell bronchogenic carcinoma
- Squamous cell
- Adenocarcinoma
- Large cell undifferentiated
- Bronchoalveolar
- Non-small cell carcinoma not otherwise stated
Unresectable stage IIIA
- Mediastinal lymph node enlargement of at least 1 cm but less than 2 cm on computed tomography (CT) scans must have mediastinotomy or thoracoscopy to rule out resectability
OR
Stage IIIB disease without significant pleural effusion
- Seen on CT scan only (not seen on chest x-ray) or does not reaccumulate after 1 thoracentesis and is cytologically negative
- Metastases to contralateral, mediastinal, or supraclavicular nodes allowed
- Bidimensionally measurable or evaluable disease
- 18 and over
- ECOG performance status 0-1
Adequate hematopoietic, hepatic, and renal function obtained <=4 weeks prior to registration:
- Platelet count at least 100,000/mm^3
- White Blood Cell (WBC) count at least 4,000/mm^3 OR absolute neutrophil count at least 2,000/mm^3
- Bilirubin normal
- Serum glutamic oxaloacetic transaminase (SGOT) no greater than 2.5 times upper limit of normal
- Creatinine no greater than 1.5 mg/dL OR creatinine clearance at least 60 mL/min
- Fertile patients must use 2 methods of effective contraception for 4 weeks prior to, during, and for 4 weeks after study therapy
- Concurrent filgrastim (G-CSF) allowed for persistent neutropenia
Exclusion Criteria:
- Positive pregnancy test,pregnant or nursing
- Uncontrolled high blood pressure, unstable angina, congestive heart failure, or myocardial infarction within the prior year
- Serious cardiac arrhythmias requiring medication
- Prior radiotherapy to only area of measurable or active tumor
- Less than 5 years since prior chemotherapy
- Other active malignancies
- Serious uncontrolled active infection
- Evidence of greater than grade 1 neuropathy by history or physical examination
- History of seizure disorders
- Contraindication to daily low-dose (81 mg/day) aspirin
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Arm A (Paclitaxel + Carboplatin + RT)
Induction chemotherapy dosing: Paclitaxel, 225 mg/m² (3 hour infusion) Day 1. Carboplatin, area under the plasma drug concentration versus time curve (AUC) =6.0, 15-30 min IV infusion immediately following paclitaxel, Day 1 Concurrent chemotherapy / radiotherapy dosing: Paclitaxel, 45 mg/m2, administered weekly during radiotherapy over one hour. Carboplatin, AUC=2, 15- 30 minutes IV infusion immediately following paclitaxel; administered weekly during radiotherapy Radiation therapy started between days 43-50 from day 1 of cycle 1. The primary tumor and areas of known nodal disease received 60 Gy at 2.0 Gy fractions, 5 fractions/week for 30 fractions over 6 weeks to the post chemotherapy tumor volume as seen on computed tomography (CT). The initial 50 Gy was delivered to target volume (TV). The final 10 Gy was delivered to a reduced volume targeting defined by TV |
Induction Chemotherapy dosing: AUC=6.0,
15-30 min IV infusion immediately following paclitaxel, Day 1 and Day 22. Concurrent Chemotherapy / Radiotherapy dosing, AUC=2; 15- 30 minutes IV infusion immediately following paclitaxel; administered weekly during radiotherapy
Altri nomi:
Induction chemotherapy dosing: 225 mg/m² (3 hour infusion) Day 1 and Day 22. Concurrent Chemotherapy / Radiotherapy dosing: 45 mg/m2; administered weekly during radiotherapy over one hour
Altri nomi:
Radiation therapy started between days 43-50 from day 1 of cycle 1.
The primary tumor and areas of known nodal disease received 60 Gy at 2.0 Gy fractions, 5 fractions/week for 30 fractions over 6 weeks to the post chemotherapy tumor volume as seen on computed tomography (CT).
The initial 50 Gy was delivered to target volume (TV).
The final 10 Gy was delivered to a reduced volume targeting defined by TV
Altri nomi:
|
|
Sperimentale: Arm B (Paclitaxel + Carboplatin + RT+ Thalidomide)
paclitaxel, carboplatin, and radiotherapy are same as those in Arm A. thalidomide: Induction chemotherapy dosing, oral daily, starting Day 1 for 24 months or until disease progression. Concurrent chemotherapy / radiotherapy dosing, oral daily, begin with 200 mg thalidomide as a single dose at bedtime. The dose is then increased by 100 mg every week as tolerated up to a total dose of 1000 mg. |
Induction Chemotherapy dosing: AUC=6.0,
15-30 min IV infusion immediately following paclitaxel, Day 1 and Day 22. Concurrent Chemotherapy / Radiotherapy dosing, AUC=2; 15- 30 minutes IV infusion immediately following paclitaxel; administered weekly during radiotherapy
Altri nomi:
Induction chemotherapy dosing: 225 mg/m² (3 hour infusion) Day 1 and Day 22. Concurrent Chemotherapy / Radiotherapy dosing: 45 mg/m2; administered weekly during radiotherapy over one hour
Altri nomi:
Radiation therapy started between days 43-50 from day 1 of cycle 1.
The primary tumor and areas of known nodal disease received 60 Gy at 2.0 Gy fractions, 5 fractions/week for 30 fractions over 6 weeks to the post chemotherapy tumor volume as seen on computed tomography (CT).
The initial 50 Gy was delivered to target volume (TV).
The final 10 Gy was delivered to a reduced volume targeting defined by TV
Altri nomi:
Induction Chemotherapy dosing: oral daily, starting Day 1 for 24 months or until disease progression.
Concurrent Chemotherapy / Radiotherapy dosing: oral daily, begin with 200 mg thalidomide as a single dose at bedtime.
The dose is then increased by 100 mg every week as tolerated up to a total dose of 1000 mg.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Overall Survival Time
Lasso di tempo: every other month until 24 months from study entry, then every 3 months for year 3, every 4 months for year 4 and every 6 months for year 5
|
Survival time is defined as time from study entry to death from any cause
|
every other month until 24 months from study entry, then every 3 months for year 3, every 4 months for year 4 and every 6 months for year 5
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time to Disease Progression
Lasso di tempo: every other month until 24 months from study entry, every 3 months for year 3, every 4 months for the 4th year and every 6 months for the 5th year
|
Time to disease progression is defined as the time from randomization to documented disease progression or to death without progression.
Patients without documented progression or death reported were censored at the time of the last documented disease evaluation.
Progression is defined, using the Response Evaluation Criteria In Solid Tumors (RECIST), as a measurable increase in the smallest dimension of any target or non-target lesion, or the appearance of new lesions, since baseline.
|
every other month until 24 months from study entry, every 3 months for year 3, every 4 months for the 4th year and every 6 months for the 5th year
|
|
Response Rate at Best Response to Treatment
Lasso di tempo: every other month until 24 months from study entry, every 3 months for year 3, every 4 months for the 4th year and every 6 months for the 5th year
|
Proportion of patients with complete or partial response using the Response Evaluation Criteria In Solid Tumors (RECIST) v1.0.
Complete response is defined as the complete disappearance of all clinically detectable malignant disease for at least 4 weeks.
Partial response is defined as greater than or equal to 50% decrease in tumor size for at least 4 weeks without increase in size of any area of known malignant disease of greater than 25%, or appearance of new areas of malignant disease.
|
every other month until 24 months from study entry, every 3 months for year 3, every 4 months for the 4th year and every 6 months for the 5th year
|
Collaboratori e investigatori
Sponsor
Investigatori
- Cattedra di studio: Joan H. Schiller, MD, Simmons Cancer Center
Pubblicazioni e link utili
Pubblicazioni generali
- Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer. 2007 Apr 23;96(8):1278-83. doi: 10.1038/sj.bjc.6603721. Epub 2007 Apr 3.
- Belinsky SA, Grimes M, Johnson D, et al.: Predicting gene promoter methylation in lung tumors through examination of sputum and serum. [Abstract] J Clin Oncol 24 (Suppl 18): A-7208, 416s, 2006.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
- carcinoma polmonare non a piccole cellule in stadio IIIA
- carcinoma polmonare non a piccole cellule in stadio IIIB
- carcinoma polmonare a cellule squamose
- carcinoma polmonare a grandi cellule
- adenocarcinoma del polmone
- carcinoma polmonare a cellule adenosquamose
- carcinoma polmonare a cellule broncoalveolari
Termini MeSH pertinenti aggiuntivi
- Malattie delle vie respiratorie
- Neoplasie
- Malattie polmonari
- Neoplasie per sede
- Neoplasie delle vie respiratorie
- Neoplasie toraciche
- Carcinoma, broncogeno
- Neoplasie bronchiali
- Neoplasie polmonari
- Carcinoma, polmone non a piccole cellule
- Effetti fisiologici delle droghe
- Meccanismi molecolari dell'azione farmacologica
- Agenti antinfettivi
- Agenti antineoplastici
- Agenti immunosoppressivi
- Fattori immunologici
- Modulatori della tubulina
- Agenti antimitotici
- Modulatori della mitosi
- Agenti antineoplastici, fitogenici
- Inibitori dell'angiogenesi
- Agenti di modulazione dell'angiogenesi
- Sostanze per la crescita
- Inibitori della crescita
- Agenti antibatterici
- Agenti leprostatici
- Carboplatino
- Paclitaxel
- Talidomide
Altri numeri di identificazione dello studio
- NCI-2012-02943
- U10CA021115 (Sovvenzione/contratto NIH degli Stati Uniti)
- E3598 (Altro identificatore: Eastern Cooperative Oncology Group (ECOG))
- CDR0000067510 (Identificatore di registro: PDQ (Physician Data Query))
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .